Mitogenic activity of staphylococcal peptidoglycan

Area of Science:

• Immunology
• Microbiology

Background:

• Staphylococcus aureus peptidoglycan is a known immunomodulatory molecule.
• The specific cell types responsible for peptidoglycan-induced immune responses require further elucidation.

Purpose of the Study:

• To investigate the mitogenic activity of Staphylococcus aureus peptidoglycan on lymphocytes.
• To identify the specific lymphocyte subset responsible for responding to peptidoglycan.

Main Methods:

• In vitro lymphocyte proliferation assays using [3H]thymidine incorporation.
• Testing mitogenic activity on mouse splenocytes, human peripheral blood lymphocytes, and athymic nude mouse spleen cells.
• Utilizing T cell-enriched and B cell-depleted mouse lymphocyte cultures.

Main Results:

• Staphylococcus aureus peptidoglycan exhibited dose-dependent mitogenic activity on mouse splenocytes and human peripheral blood lymphocytes.
• Peptidoglycan was also mitogenic for athymic nude mouse spleen cells.
• No blastogenic effect was observed in T cell-enriched and B cell-depleted mouse lymphocyte cultures.

Conclusions:

• The data strongly suggest that B lymphocytes are the primary peptidoglycan-responding cells in mouse spleen cell cultures.
• This finding contributes to understanding the immunomodulatory role of bacterial peptidoglycans.